Q Therapeutics Announces Joint Venture with REPROCELL
Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) diseases, and REPROCELL Inc., Japan’s fi
top of page
OUR NEWS
IN THE MEDIA
XABLECATH FEATURED IN MEDTECH STRATEGIST AS A STARTUP TO WATCH IN 2018
Salt Lake City, UT – May 11, 2018 – UpStart portfolio company Xablecath offering peripheral vascular interventional tech- nologies appears in the "START-UPS TO WATCH" section of the May edition of MedTech Strategist.
SERA PROGNOSTICS IS NAMED A 2017 SILVER EDISON AWARD WINNER
New York, NY – April 21, 2017 – The Edison Awards, celebrating 30 years of honoring the best in innovation and excellence in the development of new products and services, announced today that Sera Prognostics’ PreTRM Test was voted a Silver Winner for innovation in the “Health and Wellness” category at the April 20th event at The Capitale in New York City.
bottom of page